PACS, RIS, and CVIS – Market Insights – Europe
The European PACS, RIS, and CVIS market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic, driven by Europe’s increasingly aging population, and consequent rising incidences of chronic illness that are contributing to radiology and cardiology procedure volumes, as well as the ongoing trend toward hospital consolidation, along with continued efforts by manufacturers in launching digital and AI-integrated systems that are more efficient in terms of resources, workflow, and costs. However, overall market expansion will be hindered by market saturation, which is driving increased price competition among vendors, as well as facility budget constraints for capital equipment, and an increasing shift toward enterprise solutions.
This Medtech 360 Report provides comprehensive data and analysis on the of the market for PACS, RIS, and CVIS in Europe from 2019 through 2032.
The European market for PACS, RIS, and CVIS is nearing saturation across many facility types.
What is the penetration of PACS, RIS, and CVIS in Europe across the different facility types and countries?
What is the expected volume of replacement sales in each country through 2032?
Adoption of new emerging technologies as replacements for traditional PACS, RIS, and CVIS will rapidly change market prospects.
What are the emerging technologies that are affecting the future of the traditional PACS, RIS, and CVIS markets?
How will the adoption of enhanced diagnostic tools such as AI and machine learning change the market and what are the competitive implications of this technology?
How will widespread adoption of EHRs and VNAs affect the PACS, RIS, and CVIS markets?
Hospital consolidation is driving demand for high-value PACS, RIS, and CVIS contracts.
How will hospital consolidation and an unequal distribution of radiologists in Europe affect the pace of HCIT system upgrades?
Cybersecurity in the HCIT sector is a growing topic of discussion, and vendors are increasingly investing in improving the security of their systems.
How will growing demand for cybersecurity services impact overall PACS, RIS, and CVIS implementations?
Vendors of PACS, RIS, and CVIS must develop new competitive strategies to address the evolving purchasing priorities and needs of healthcare facilities.
How will mergers and acquisitions change the competitive landscape of the PACS, RIS, and CVIS market?
How will AI integration affect the competitiveness of certain companies?
Table of contents
- PACS, RIS, and CVIS - Market Insights - Europe
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- PACS, RIS, and CVIS Market
- Radiology PACS Market
- RIS Market
- CVIS/CPACS Market
- Appendix
Sumit Jain is a senior team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor’s degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master’s degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.